FASN and nasopharyngeal carcinoma: Separate studies reported that LMP1, the major transforming oncoprotein in vitro during EBV latent infection, upregulated FASN levels (21, 147, 148) in both nasopharyngeal carcinoma and B-cells, through different mechanisms.